eslicarbazepine acetate has been researched along with warfarin in 1 studies
| Studies (eslicarbazepine acetate) | Trials (eslicarbazepine acetate) | Recent Studies (post-2010) (eslicarbazepine acetate) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 229 | 68 | 175 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | eslicarbazepine acetate (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almeida, L; Falcão, A; Maia, J; Nunes, T; Soares, E; Soares-da-Silva, P; Vaz-da-Silva, M | 1 |
1 trial(s) available for eslicarbazepine acetate and warfarin
| Article | Year |
|---|---|
Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Topics: Adult; Anticoagulants; Area Under Curve; Blood Coagulation; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Dibenzazepines; Dose-Response Relationship, Drug; Female; Humans; International Normalized Ratio; Male; Sodium Channel Blockers; Tandem Mass Spectrometry; Time Factors; Warfarin; Young Adult | 2010 |